Thanks very much for your kind email. I have been very very satisfied with
your service and products - indeed, they have saved my relationship, after
serious psot-trauamtic disorder after long periods serving in the wars in
Bosnia, Afghanistan and Iraq.
It was perfect as expected and faster than i thought.
Yes, I received my order and it was much more descrete than getting it by
certified mail. You have the best system.
Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
Aurobindo gets USFDA nod for anti-HIV drugs - Hindu Business Line
Aurobindo gets USFDA nod for anti-HIV drugsHindu Business LineAurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Lamivudine and Zidovudine tablets.
South Africa exceeds 2007-11 treatment targets by 50% - aidsmap
South Africa exceeds 2007-11 treatment targets by 50%aidsmapCrude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently.
Patent expires of landmark HIV drug Combivir - U-T San Diego
Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.
LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.